Highly expressed in neural tissues, GSK-3β has been implicated in several neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and schizophrenia [11], [12], [13]. Here, GSK3B is linked to early-onset autosomal dominant Alzheimer disease.